Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

ACTH 1-17 effects in oncology.

T Battelli, R Mattioli, P Manocchi

    La Ricerca in Clinica E in Laboratorio
    |April 1, 1984
    PubMed
    Summary

    This study found that Synchrodyn-17 peptide treatment in cancer patients undergoing chemotherapy reduced nausea, vomiting, and weakness. However, it also led to side effects like skin pigmentation, sodium retention, and hypertension.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Systemic injection of an H4 receptor agonist induces a decrease in CREB and pCREB levels in the cerebellar vermis and prefrontal cortex in mice.

    Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas·2019
    Same author

    Intra-vermis H4 receptor agonist impairs performance in anxiety- and fear-mediated models.

    Brain research bulletin·2017
    Same author

    Cholinergic agonist reverses H1-induced memory deficit in mice.

    Progress in neuro-psychopharmacology & biological psychiatry·2016
    Same author

    Automatic Identification of the Repolarization Endpoint by Computing the Dominant T-wave on a Reduced Number of Leads.

    The open biomedical engineering journal·2016
    Same author

    Intra-amygdala microinjections of chlorpheniramine impair memory formation or memory retrieval in anxiety- and fear-mediated models.

    Brain research bulletin·2016
    Same author

    The consolidation of inhibitory avoidance memory in mice depends on the intensity of the aversive stimulus: The involvement of the amygdala, dorsal hippocampus and medial prefrontal cortex.

    Neurobiology of learning and memory·2016

    Area of Science:

    • Oncology
    • Pharmacology

    Background:

    • Cytotoxic chemotherapy regimens (CMF, FAC, FAM) are associated with significant side effects.
    • Nausea, vomiting, and weakness are common and distressing chemotherapy-induced side effects.
    • The peptide Synchrodyn-17 is being investigated for its potential to mitigate these side effects.

    Purpose of the Study:

    • To evaluate the efficacy of Synchrodyn-17 in reducing chemotherapy-induced side effects.
    • To assess the impact of Synchrodyn-17 on patient performance status.
    • To identify any adverse effects associated with Synchrodyn-17 administration.

    Main Methods:

    • A study involving 90 cancer patients receiving cytotoxic chemotherapy.
    • Treatment group received Synchrodyn-17 (100 micrograms i.m. daily for 15 days).
    • Control group received a placebo.

    Main Results:

    • Synchrodyn-17 significantly reduced nausea, vomiting, and weakness compared to placebo.
    • Patient performance status remained unchanged.
    • Observed side effects included skin pigmentation, sodium retention, hypertension, and hyperglycemia.

    Conclusions:

    • Synchrodyn-17 demonstrates potential in alleviating key side effects of chemotherapy.
    • Sustained high-dose peptide treatment may cause specific adverse effects.
    • Further research is needed to understand the peptide's full impact and optimize its use.

    Related Experiment Videos